Article Information
History
- March 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Christopher R. M. Asquitha,b,*,
- Graham J. Tizzardc,
- James M. Bennettd,
- Carrow I. Wellsb,
- Jonathan M. Elkinsd,e,
- Timothy M. Willsonb,
- Antti Posof,g and
- Tuomo Laitinenf
- aDepartment of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, NC 27599, (USA), E-mail: chris.asquith{at}unc.edu
- bStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, (USA)
- cSchool of Chemistry, University of Southampton, Southampton, SO17 1BJ, (UK)
- dStructural Genomics Consortium and Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ, (UK)
- eStructural Genomics Consortium, Universidade Estadual de Campinas - UNICAMP, Campinas, São Paulo, 13083-886, (Brazil)
- fSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70211 Kuopio, (Finland)
- gUniversity Hospital Tübingen, Department of Internal Medicine VIII, University of Tübingen, 72076 Tübingen (Germany)
- ↵*Corresponding author; email: chris.asquith{at}unc.edu
Posted March 07, 2020.
Targeting the water network in cyclin G associated kinase (GAK) with 4-anilino-quin(az)oline inhibitors
